CARDIFF ONCOLOGY, INC. Exchange Rate Effect on Cash
CARDIFF ONCOLOGY, INC. (CRDF) reported Exchange Rate Effect on Cash of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Cash Flow
us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents · last filed 2019-03-06
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2018-03-31 was $0.00.
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2017-03-31 was -$844.00.
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2016-03-31 was -$34.00.
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for the quarter ending 2015-03-31 was $0.00.
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for fiscal 2017 was $7.57K.
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for fiscal 2016 was -$5.83K.
- CARDIFF ONCOLOGY, INC. effect of exchange rate on cash and cash equivalents for fiscal 2015 was $0.00.
| Period end | Effect of Exchange Rate on Cash and Cash Equivalents 3 month | Effect of Exchange Rate on Cash and Cash Equivalents 6 month | Effect of Exchange Rate on Cash and Cash Equivalents 9 month | Effect of Exchange Rate on Cash and Cash Equivalents 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | |||
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $7.57K 10-K · filed 2019-03-06 | |||
| 2017-09-30 | -$8.84K 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $2.41K 10-Q · filed 2018-08-03 | |||
| 2017-03-31 | -$844.00 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$5.83K 10-K · filed 2018-02-26 | |||
| 2016-09-30 | -$1.54K 10-Q · filed 2017-11-09 | |||
| 2016-06-30 | -$2.47K 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | -$34.00 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |